Nexelis, a provider of advanced assay development and laboratory testing services in the infectious, oncologic, and metabolic diseases fields, has acquired AIT Bioscience, an integrated bioanalytical laboratory with LC-MS and immunoassay testing capabilities and operates a paperless FDA-inspected facility supported by state-of-the-art electronic systems. Benoit Bouche, Nexelis President and Chief Executive Officer said, “This is our fourth acquisition since 2018 and we are excited for AIT Bi...